Why NAD+ Supplements Are a Waste of Money

Your cells are not running low on NAD+ because your body forgot how to make it. They are running low because something is consuming it faster than your body can replace it, and that distinction changes everything about what you should actually do.

To understand why, you need the full picture first.

NAD+ is something called a coenzyme, which is a molecule that enzymes need to do their jobs. Your mitochondria use it to convert food into usable energy, your repair enzymes use it to fix broken DNA, and your sirtuins use it to regulate gene expression and cellular maintenance. When NAD+ levels drop, all of those systems slow down at once, which is why declining NAD+ is so closely tied to the general picture of aging.

The standard explanation you will hear is that your body simply produces less NAD+ as you get older, and that you can fix this by swallowing a precursor supplement like NMN or NR that gives your cells the raw materials to make more. That part is not entirely wrong. Precursor availability does matter at the margins. But it misses what is actually driving the decline, and that is where most people's money goes.

As you age, your body accumulates what are called senescent cells, which are damaged cells that stopped dividing but refused to die. A healthy immune system would clear these out through a process called apoptosis, but when the clearance system falls behind, they pile up and stay. And they do not stay quietly. Senescent cells secrete a cocktail of inflammatory signals called the senescence-associated secretory phenotype, and those signals reach your immune cells and tell them that something is wrong, which is true, but the immune response that follows has a steep metabolic cost.

Here is where the consumption problem begins.

Those inflammatory signals cause immune cells called macrophages to dramatically upregulate an enzyme called CD38, which is a protein that uses NAD+ as raw material to produce signaling molecules the immune system needs to coordinate its response. Research published in Nature Metabolism found that this upregulation is not modest. Macrophages exposed to senescent cell secretions increased their CD38 expression by up to 600-fold, and those CD38-high macrophages then consumed NAD+ from surrounding tissues to fuel the ongoing inflammatory response.

The 2016 Cell Metabolism paper put numbers on what this looks like across the whole organism. CD38 activity increases two to three-fold in tissues across the body as you age, and the correlation between rising CD38 and falling NAD+ is nearly perfect. When researchers knocked out the CD38 gene in mice entirely, NAD+ levels stayed constant at every age tested. The mice that aged normally lost NAD+ steadily. The CD38 knockout mice did not. Your body is not producing less NAD+. Something is eating it.

Damaged mitochondria compound this. Mitochondria accumulate wear over time, and when their membranes and electron transport chains are compromised, they generate more oxidative stress and more signals indicating DNA damage. That damage activates a family of repair enzymes called PARPs, which stands for poly ADP-ribose polymerases, and PARPs use NAD+ as their substrate to tag broken DNA strands for repair. Every repair cycle burns through NAD+. So you have two major consumers running simultaneously: CD38 burning NAD+ to fuel inflammation, and PARPs burning NAD+ to address the downstream damage that inflammation causes.

Taking an NAD+ precursor supplement in this environment is like pouring water into a bathtub where the drain is wide open. You can keep pouring, but the water level does not rise, because nothing has addressed the rate of outflow.

This is also what the gut biology makes worse. Research from 2023 found that gut bacteria intercept NMN before it reaches your tissues and convert it through a process called deamidation into nicotinic acid, which is plain niacin. A separate Science Advances study confirmed that most oral precursors are entering the NAD+ synthesis pathway as niacin anyway, after conversion in the gut. So not only are you addressing the wrong problem, but the expensive precursor you bought is likely becoming the cheapest vitamin in your cabinet before it ever reaches your cells.

A review of 25 human studies on NR supplementation, published in Science Advances, concluded that there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects. That is the scientific literature's way of saying the results look much smaller in the real world than in the press releases.

So if the problem is consumption, the fix has to address what is doing the consuming.

Exercise is the most accessible lever here. A 2023 systematic review with meta-analysis found that exercise training increases the expression of something called NAMPT, which is the enzyme that recycles NAD+ back into usable form. The increase was over 127% with a large effect size of 0.81, which is substantial in human physiology research. Exercise does not just burn calories. It directly upregulates the recycling machinery that your NAD+ system depends on.

Clearing senescent cells addresses the upstream source of the CD38 activation problem. A peptide called FOXO4-DRI was developed to restore the apoptosis signal in senescent cells, effectively telling them to complete the death process they stalled out of. Removing the senescent cells removes the inflammatory signals, which removes the trigger for CD38 upregulation in macrophages, which reduces the rate of NAD+ consumption.

Repairing mitochondrial membrane integrity addresses the PARP activation problem. A peptide called SS-31 targets the inner mitochondrial membrane specifically, where it reduces oxidative stress at the source. A 2020 Aging Cell study found that in aged mouse hearts, neither SS-31 nor NMN alone significantly increased NAD+ levels at rest. Only the combination did, and it was the combination that most closely recapitulated the metabolic profile of young tissue. SS-31 alone reduced the damage driving PARP activation. Adding the precursor on top of a functioning system, with the drain partially closed, actually moved the needle.

That last finding matters because it tells you the correct sequence. Fix the drain first. Then add precursor support if you want it, and at that point, plain niacin does the job at a fraction of the cost of NMN or NR, since the gut was going to convert them to niacin anyway.

The reason NAD+ supplements became a billion-dollar industry is that the story they tell is simple: your levels drop, so you top them up. But your body is not a static tank. It is a system with inputs and outputs, and the output side is where the aging process hits first. A supplement that addresses the input while ignoring the output is not solving the problem. It is just making the drain less obvious.

---

References

1. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across all tissues, with near-perfect inverse correlation to NAD+ levels. CD38 knockout mice maintained NAD+ at all ages. Source
2. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cells secrete inflammatory cytokines that cause macrophages to upregulate CD38 expression up to 600-fold, establishing the causal chain from cellular senescence to NAD+ decline. Source
3. Kim LJ, Chalmers TJ, Madawala R, et al. Host-microbiome interactions in nicotinamide mononucleotide NMN deamidation. FEBS Letters. 2023;59717:2196-2207. Finding: Gut bacteria deamidate NMN before absorption, converting it to nicotinic acid niacin. Ablation of microbiome with antibiotics increased direct NMN uptake, confirming gut conversion. Source
4. Science Advances enterohepatic circulation study. Finding: NMN and NR facilitate NAD+ synthesis primarily through conversion to niacin-pathway metabolites in the gut, confirming that most oral precursors become niacin before absorption. Source
5. Sun X, Su L, Bu T, Zhang Y. Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis. Frontiers in Public Health. 2023;11:1287421. Finding: Exercise training increases NAMPT expression by over 127% with a large effect size Cohen's d = 0.81. Source
6. Whitson JA, Martin SS, Zhang H, et al. SS-31 and NMN: Two paths to improve metabolism and function in aged hearts. Aging Cell. 2020;1910:e13213. Finding: Neither SS-31 nor NMN alone significantly increased resting NADH levels in aged mouse hearts. Only the combination did, best recapitulating the young state. Source
7. Brakedal B, Doring A, Riber C, et al. What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances. 2023;929:eadi4862. Finding: Review of 25 NR human studies concluded there is "an unfortunate tendency in the literature to exaggerate" the importance and robustness of reported effects. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness